Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-06-20 06:05 am Sale |
2023-06-16 | 13D | Lumos Pharma, Inc. LUMO |
Farb Daniel Stuart | 400,000 4.900% |
-96,891 (-19.50%) |
Filing History |
| 2023-06-02 11:14 am Sale |
2023-05-30 | 13D | Lumos Pharma, Inc. LUMO |
Farb Daniel Stuart | 496,891 6.080% |
-146,447 (-22.76%) |
Filing History |
| 2023-05-25 12:10 pm Sale |
2023-05-24 | 13D | Lumos Pharma, Inc. LUMO |
Farb Daniel Stuart | 643,338 7.870% |
-116,662 (-15.35%) |
Filing History |
| 2023-02-14 6:25 pm Unchanged |
2023-02-13 | 13D | Lumos Pharma, Inc. LUMO |
Farb Daniel Stuart | 760,000 9.070% |
0 (Unchanged) |
Filing History |
| 2023-01-24 12:58 pm Purchase |
2023-01-25 | 13G | Lumos Pharma, Inc. LUMO |
Farb Daniel Stuart | 760,000 9.070% |
263,189 (+52.98%) |
Filing History |
| 2022-02-02 2:44 pm Unchanged |
2022-01-27 | 13G | Lumos Pharma, Inc. LUMO |
Farb Daniel Stuart | 496,811 5.940% |
0 (Unchanged) |
Filing History |
| 2022-01-31 5:34 pm Purchase |
2022-01-27 | 13G | Lumos Pharma, Inc. LUMO |
Farb Daniel Stuart | 496,811 5.940% |
496,811 (New Position) |
Filing History |